HEADER TRANSFERASE 04-OCT-16 5M0B TITLE COCRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX TITLE 2 WITH A SHORT-CHAINED N-(2-AMINOETHYL)ISOQUINOLINE-5-SULFONAMIDE) TITLE 3 FASUDIL-DERIVATIVE (LIGAND 03) COMPND MOL_ID: 1; COMPND 2 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PKA C-ALPHA; COMPND 5 EC: 2.7.11.11; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: PHOSPHORYLATED AT SER11, THR198, SER339; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE INHIBITOR ALPHA; COMPND 10 CHAIN: B; COMPND 11 SYNONYM: PKI-ALPHA,CAMP-DEPENDENT PROTEIN KINASE INHIBITOR, COMPND 12 MUSCLE/BRAIN ISOFORM; COMPND 13 ENGINEERED: YES; COMPND 14 OTHER_DETAILS: AMINO ACIDS 5-24 FROM CAMP-DEPENDENT PROTEIN KINASE COMPND 15 INHIBITOR ALPHA FROM SIGMA (ORDER ID: P7739); THE LAST AMINO ACID IS COMPND 16 NOT WELL DEFINED IN THE CRYSTAL STRUCTURE SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CRICETULUS GRISEUS; SOURCE 3 ORGANISM_COMMON: CHINESE HAMSTER; SOURCE 4 ORGANISM_TAXID: 10029; SOURCE 5 GENE: PRKACA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606 KEYWDS PKA, KINASE, FASUDIL-DERIVATIVE, INHIBITION, COCRYSTAL, 3X- KEYWDS 2 PHOSPHORYLATED, TRANSFERASE, LIGAND 03 EXPDTA X-RAY DIFFRACTION AUTHOR B.WIENEN-SCHMIDT,A.HEINE,G.KLEBE REVDAT 2 17-JAN-24 5M0B 1 REMARK REVDAT 1 06-JUN-18 5M0B 0 JRNL AUTH B.WIENEN-SCHMIDT,H.R.A.JONKER,H.-D.GERBER,K.SAXENA, JRNL AUTH 2 D.KUDLINZKI,S.SREERAMULU,A.HEINE,H.SCHWALBE,G.KLEBE JRNL TITL COCRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) JRNL TITL 2 IN COMPLEX WITH DIFFERENT FASUDIL-DERIVATIVES JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.51 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.10.1_2155: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.51 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.88 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 73039 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.133 REMARK 3 R VALUE (WORKING SET) : 0.132 REMARK 3 FREE R VALUE : 0.159 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3652 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 39.8905 - 4.4605 1.00 2872 151 0.1511 0.1709 REMARK 3 2 4.4605 - 3.5411 1.00 2759 145 0.1287 0.1426 REMARK 3 3 3.5411 - 3.0937 1.00 2735 144 0.1412 0.1411 REMARK 3 4 3.0937 - 2.8109 1.00 2693 142 0.1394 0.1512 REMARK 3 5 2.8109 - 2.6095 1.00 2701 142 0.1382 0.1542 REMARK 3 6 2.6095 - 2.4557 1.00 2697 142 0.1268 0.1495 REMARK 3 7 2.4557 - 2.3327 1.00 2670 140 0.1249 0.1507 REMARK 3 8 2.3327 - 2.2312 1.00 2659 140 0.1189 0.1575 REMARK 3 9 2.2312 - 2.1453 1.00 2657 140 0.1161 0.1460 REMARK 3 10 2.1453 - 2.0712 1.00 2678 141 0.1211 0.1500 REMARK 3 11 2.0712 - 2.0065 1.00 2650 140 0.1281 0.1557 REMARK 3 12 2.0065 - 1.9491 1.00 2689 141 0.1255 0.1485 REMARK 3 13 1.9491 - 1.8978 1.00 2644 139 0.1222 0.1721 REMARK 3 14 1.8978 - 1.8515 1.00 2660 140 0.1191 0.1497 REMARK 3 15 1.8515 - 1.8094 1.00 2631 139 0.1181 0.1669 REMARK 3 16 1.8094 - 1.7709 1.00 2647 139 0.1119 0.1590 REMARK 3 17 1.7709 - 1.7355 1.00 2677 141 0.1123 0.1593 REMARK 3 18 1.7355 - 1.7027 1.00 2596 137 0.1164 0.1747 REMARK 3 19 1.7027 - 1.6723 1.00 2671 140 0.1219 0.1577 REMARK 3 20 1.6723 - 1.6440 1.00 2629 138 0.1249 0.1829 REMARK 3 21 1.6440 - 1.6175 1.00 2639 139 0.1531 0.2096 REMARK 3 22 1.6175 - 1.5926 0.99 2607 138 0.1512 0.2135 REMARK 3 23 1.5926 - 1.5692 1.00 2655 140 0.1373 0.1894 REMARK 3 24 1.5692 - 1.5471 1.00 2643 139 0.1458 0.2158 REMARK 3 25 1.5471 - 1.5262 1.00 2613 137 0.1557 0.1884 REMARK 3 26 1.5262 - 1.5063 0.99 2615 138 0.1743 0.2699 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.120 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 14.180 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 3161 REMARK 3 ANGLE : 0.955 4287 REMARK 3 CHIRALITY : 0.062 452 REMARK 3 PLANARITY : 0.007 565 REMARK 3 DIHEDRAL : 15.404 1874 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5M0B COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 04-OCT-16. REMARK 100 THE DEPOSITION ID IS D_1200001675. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-APR-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.9 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM14 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97625 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 73047 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.506 REMARK 200 RESOLUTION RANGE LOW (A) : 45.080 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 7.320 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05400 REMARK 200 FOR THE DATA SET : 26.2800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.51 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.60 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 7.26 REMARK 200 R MERGE FOR SHELL (I) : 0.49800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.890 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1Q8W REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.33 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: DROP: 10 MG/ML PKA (0.240 MM) 30 MM REMARK 280 MBT (MES/BIS-TRIS PUFFER PH 6.9) 1 MM DTT 0.1 MM EDTA 75 MM LICL REMARK 280 0.03 MM MEGA 8 0.07MM PKI (SIGMA: P7739) 1.2 MM LIGAND SOLVED IN REMARK 280 DMSO (50 MM STOCK) RESERVOIR: 18% METHANOL 0.003 ML DROP VOLUME, REMARK 280 0.4 ML RESERVOIR VOLUME, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.97250 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 54.96100 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.86800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 54.96100 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.97250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.86800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3000 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16770 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -11.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP B 24 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 21 CD CE NZ REMARK 470 LYS A 28 CD CE NZ REMARK 470 ARG A 45 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 61 NZ REMARK 470 LYS A 81 CD CE NZ REMARK 470 LYS A 254 CG CD CE NZ REMARK 470 LYS A 285 CD CE NZ REMARK 470 LYS A 295 CD CE NZ REMARK 470 GLU A 311 CD OE1 OE2 REMARK 470 LYS A 317 CG CD CE NZ REMARK 470 PHE A 318 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 319 CG CD CE NZ REMARK 470 GLU A 331 CG CD OE1 OE2 REMARK 470 GLU A 334 CG CD OE1 OE2 REMARK 470 HIS B 23 CG ND1 CD2 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 144 NE - CZ - NH1 ANGL. DEV. = -3.1 DEGREES REMARK 500 ARG A 144 NE - CZ - NH2 ANGL. DEV. = 3.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 166 46.12 -146.89 REMARK 500 ASP A 184 92.16 73.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue IQU A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MPD A 402 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5LCP RELATED DB: PDB REMARK 900 5LCP CONTAINS THE SAME PROTEIN IN COMPLEX WITH THE STRUCTURALLY REMARK 900 RELATED DRUG FASUDIL (M77) REMARK 900 RELATED ID: 5LCQ RELATED DB: PDB REMARK 900 5LCQ CONTAINS THE SAME PROTEIN IN COMPLEX WITH THE STRUCTURALLY REMARK 900 RELATED LONG-CHAINED FASUDIL-DERIVATIVE REMARK 900 RELATED ID: 5LCR RELATED DB: PDB REMARK 900 5LCR CONTAINS THE SAME PROTEIN IN COMPLEX WITH A STRUCTURALLY REMARK 900 RELATED OPEN-CHAINED FASUDIL-DERIVATIVE REMARK 900 RELATED ID: 5LCT RELATED DB: PDB REMARK 900 5LCT CONTAINS THE SAME PROTEIN IN COMPLEX WITH A STRUCTURALLY REMARK 900 RELATED R-METHYL-PIERAZINE SUBSTITUTED FASUDIL-DERIVATIVE REMARK 900 RELATED ID: 5LCU RELATED DB: PDB REMARK 900 5LCU CONTAINS THE SAME PROTEIN IN COMPLEX WITH A STRUCTURALLY REMARK 900 RELATED S-METHYL-PIERAZINE SUBSTITUTED FASUDIL-DERIVATIVE DBREF 5M0B A 0 350 UNP P25321 KAPCA_CRIGR 1 351 DBREF 5M0B B 5 24 UNP P61925 IPKA_HUMAN 6 25 SEQADV 5M0B GLY A -2 UNP P25321 EXPRESSION TAG SEQADV 5M0B HIS A -1 UNP P25321 EXPRESSION TAG SEQRES 1 A 353 GLY HIS MET GLY ASN ALA ALA ALA ALA LYS LYS GLY SEP SEQRES 2 A 353 GLU GLN GLU SER VAL LYS GLU PHE LEU ALA LYS ALA LYS SEQRES 3 A 353 GLU GLU PHE LEU LYS LYS TRP GLU SER PRO SER GLN ASN SEQRES 4 A 353 THR ALA GLN LEU ASP HIS PHE ASP ARG ILE LYS THR LEU SEQRES 5 A 353 GLY THR GLY SER PHE GLY ARG VAL MET LEU VAL LYS HIS SEQRES 6 A 353 LYS GLU THR GLY ASN HIS TYR ALA MET LYS ILE LEU ASP SEQRES 7 A 353 LYS GLN LYS VAL VAL LYS LEU LYS GLN ILE GLU HIS THR SEQRES 8 A 353 LEU ASN GLU LYS ARG ILE LEU GLN ALA VAL ASN PHE PRO SEQRES 9 A 353 PHE LEU VAL LYS LEU GLU PHE SER PHE LYS ASP ASN SER SEQRES 10 A 353 ASN LEU TYR MET VAL MET GLU TYR VAL PRO GLY GLY GLU SEQRES 11 A 353 MET PHE SER HIS LEU ARG ARG ILE GLY ARG PHE SER GLU SEQRES 12 A 353 PRO HIS ALA ARG PHE TYR ALA ALA GLN ILE VAL LEU THR SEQRES 13 A 353 PHE GLU TYR LEU HIS SER LEU ASP LEU ILE TYR ARG ASP SEQRES 14 A 353 LEU LYS PRO GLU ASN LEU LEU ILE ASP GLN GLN GLY TYR SEQRES 15 A 353 ILE GLN VAL THR ASP PHE GLY PHE ALA LYS ARG VAL LYS SEQRES 16 A 353 GLY ARG THR TRP TPO LEU CYS GLY THR PRO GLU TYR LEU SEQRES 17 A 353 ALA PRO GLU ILE ILE LEU SER LYS GLY TYR ASN LYS ALA SEQRES 18 A 353 VAL ASP TRP TRP ALA LEU GLY VAL LEU ILE TYR GLU MET SEQRES 19 A 353 ALA ALA GLY TYR PRO PRO PHE PHE ALA ASP GLN PRO ILE SEQRES 20 A 353 GLN ILE TYR GLU LYS ILE VAL SER GLY LYS VAL ARG PHE SEQRES 21 A 353 PRO SER HIS PHE SER SER ASP LEU LYS ASP LEU LEU ARG SEQRES 22 A 353 ASN LEU LEU GLN VAL ASP LEU THR LYS ARG PHE GLY ASN SEQRES 23 A 353 LEU LYS ASN GLY VAL ASN ASP ILE LYS ASN HIS LYS TRP SEQRES 24 A 353 PHE ALA THR THR ASP TRP ILE ALA ILE TYR GLN ARG LYS SEQRES 25 A 353 VAL GLU ALA PRO PHE ILE PRO LYS PHE LYS GLY PRO GLY SEQRES 26 A 353 ASP THR SER ASN PHE ASP ASP TYR GLU GLU GLU GLU ILE SEQRES 27 A 353 ARG VAL SEP ILE ASN GLU LYS CYS GLY LYS GLU PHE THR SEQRES 28 A 353 GLU PHE SEQRES 1 B 20 THR THR TYR ALA ASP PHE ILE ALA SER GLY ARG THR GLY SEQRES 2 B 20 ARG ARG ASN ALA ILE HIS ASP MODRES 5M0B SEP A 10 SER MODIFIED RESIDUE MODRES 5M0B TPO A 197 THR MODIFIED RESIDUE MODRES 5M0B SEP A 338 SER MODIFIED RESIDUE HET SEP A 10 14 HET TPO A 197 17 HET SEP A 338 14 HET IQU A 401 17 HET MPD A 402 8 HET MOH A 403 2 HET MOH B 101 2 HETNAM SEP PHOSPHOSERINE HETNAM TPO PHOSPHOTHREONINE HETNAM IQU N-(2-AMINOETHYL)ISOQUINOLINE-5-SULFONAMIDE HETNAM MPD (4S)-2-METHYL-2,4-PENTANEDIOL HETNAM MOH METHANOL HETSYN SEP PHOSPHONOSERINE HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 SEP 2(C3 H8 N O6 P) FORMUL 1 TPO C4 H10 N O6 P FORMUL 3 IQU C11 H13 N3 O2 S FORMUL 4 MPD C6 H14 O2 FORMUL 5 MOH 2(C H4 O) FORMUL 7 HOH *505(H2 O) HELIX 1 AA1 GLY A 1 SER A 32 1 32 HELIX 2 AA2 GLN A 39 ASP A 41 5 3 HELIX 3 AA3 LYS A 76 LEU A 82 1 7 HELIX 4 AA4 GLN A 84 VAL A 98 1 15 HELIX 5 AA5 GLU A 127 GLY A 136 1 10 HELIX 6 AA6 SER A 139 LEU A 160 1 22 HELIX 7 AA7 LYS A 168 GLU A 170 5 3 HELIX 8 AA8 THR A 201 LEU A 205 5 5 HELIX 9 AA9 ALA A 206 LEU A 211 1 6 HELIX 10 AB1 LYS A 217 GLY A 234 1 18 HELIX 11 AB2 GLN A 242 GLY A 253 1 12 HELIX 12 AB3 SER A 262 LEU A 273 1 12 HELIX 13 AB4 VAL A 288 ASN A 293 1 6 HELIX 14 AB5 HIS A 294 ALA A 298 5 5 HELIX 15 AB6 ASP A 301 GLN A 307 1 7 HELIX 16 AB7 GLY A 344 THR A 348 5 5 HELIX 17 AB8 THR B 6 SER B 13 1 8 SHEET 1 AA1 5 PHE A 43 GLY A 52 0 SHEET 2 AA1 5 GLY A 55 HIS A 62 -1 O LEU A 59 N LYS A 47 SHEET 3 AA1 5 HIS A 68 ASP A 75 -1 O MET A 71 N MET A 58 SHEET 4 AA1 5 ASN A 115 GLU A 121 -1 O MET A 120 N ALA A 70 SHEET 5 AA1 5 LEU A 106 LYS A 111 -1 N PHE A 110 O TYR A 117 SHEET 1 AA2 2 LEU A 162 ILE A 163 0 SHEET 2 AA2 2 LYS A 189 ARG A 190 -1 O LYS A 189 N ILE A 163 SHEET 1 AA3 2 LEU A 172 ILE A 174 0 SHEET 2 AA3 2 ILE A 180 VAL A 182 -1 O GLN A 181 N LEU A 173 LINK C GLY A 9 N SEP A 10 1555 1555 1.32 LINK C SEP A 10 N GLU A 11 1555 1555 1.33 LINK C TRP A 196 N TPO A 197 1555 1555 1.33 LINK C TPO A 197 N LEU A 198 1555 1555 1.32 LINK C VAL A 337 N SEP A 338 1555 1555 1.33 LINK C SEP A 338 N ILE A 339 1555 1555 1.33 SITE 1 AC1 13 LEU A 49 GLY A 50 THR A 51 VAL A 57 SITE 2 AC1 13 ALA A 70 GLU A 121 VAL A 123 GLU A 127 SITE 3 AC1 13 GLU A 170 LEU A 173 PHE A 327 HOH A 740 SITE 4 AC1 13 HOH A 757 SITE 1 AC2 7 VAL A 15 PHE A 18 LEU A 152 GLU A 155 SITE 2 AC2 7 TYR A 306 HOH A 689 HOH A 768 CRYST1 57.945 71.736 109.922 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017258 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013940 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009097 0.00000